|Articles|July 29, 2020

Pharmaceutical Executive Global Digest®

Click here to download the August 2020 edition.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

Pharmaceutical Executive Global Digest®

Related Content

U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels

The Benefits and Challenges of 100 Percent US-Based Manufacturing

Pharmaceutical Executive Daily: China's Latest Policy Guidance

China Pharma Trends: Premium Pricing and Priority Access for True Innovations

Trending on PharmExec

Launch is Just the Beginning: Rare Disease Care Requires Durability

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

FDA Pauses Release of New CRL’s Following Citizen’s Petition

Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena

FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma